REVIEW
|
doi:10.20944/preprints202210.0008.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
relapsed-refractory multiple myeloma; overall survival; CAR-T; non CAR-T agents
Online: 3 October 2022 (12:16:01 CEST)
CASE REPORT
|
doi:10.20944/preprints202410.1597.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Relapsed refractory multiple myeloma; RRMM; Tumor lysis syndrome; TLS; BCL-2; t(11:14); Carfilzomib; Dexamethasone
Online: 21 October 2024 (13:54:31 CEST)
REVIEW
|
doi:10.20944/preprints202410.0776.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
systematic literature review; real-world data; relapsed-refractory multiple myeloma; bispecific antibodies; B-cell maturation antigen; teclistamab; cytokine release syndrome; immune effector cell-associated neurotoxicity syndrome
Online: 10 October 2024 (09:47:05 CEST)
REVIEW
|
doi:10.20944/preprints202307.1943.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
diffuse large B-cell lymphoma. relapsed/refractory; therapy; efficacy; toxicity
Online: 28 July 2023 (03:55:02 CEST)
REVIEW
|
doi:10.20944/preprints202009.0718.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Relapsed or Refractory Diffuse Large B Cell Lymphoma, DLBLC, immunotherapy, chemotherapy-free regimen
Online: 29 September 2020 (15:09:47 CEST)
REVIEW
|
doi:10.20944/preprints202307.0430.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hodgkin lymphoma; relapsed/refractory; brentuximab vedotin; checkpoint inhibitor; PD-1 inhibitor; nivolumab; pembrolizumab; autologous hematopoietic cell transplantation
Online: 6 July 2023 (11:44:13 CEST)
ARTICLE
|
doi:10.20944/preprints202310.1339.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
mycosis fungoides; relapsed/refractory; treatment patterns; Europe; real-world data; observational study; overall survival; progression-free survival
Online: 20 October 2023 (12:08:51 CEST)
ARTICLE
|
doi:10.20944/preprints202307.0475.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
modified citrus pectin; non-metastatic biochemically relapsed prostate cancer
Online: 7 July 2023 (10:29:02 CEST)
ARTICLE
|
doi:10.20944/preprints202305.1500.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
diffuse large B-cell lymphoma; relapsed; refractory; autologous stem cell transplantation
Online: 22 May 2023 (10:29:20 CEST)
REVIEW
|
doi:10.20944/preprints202304.1236.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
FLT3 mutations; resistant/relapsed acute myeloid leukemia; tyrosine kinase inhibitors; gilteritinib
Online: 29 April 2023 (10:55:21 CEST)
REVIEW
|
doi:10.20944/preprints202109.0212.v1
Subject:
Biology And Life Sciences,
Cell And Developmental Biology
Keywords:
BCMA; CAR T cell; Multiple Myeloma; Refractory/Relapsed; ADCs; Bispecific Antibody
Online: 13 September 2021 (12:36:12 CEST)
ARTICLE
|
doi:10.20944/preprints202308.1193.v1
Subject:
Medicine And Pharmacology,
Obstetrics And Gynaecology
Keywords:
DNA methylation; DNA methyltransferases; DNMT, ovarian cancer; high grade ovarian cancer; relapsed ovarian cancer
Online: 16 August 2023 (10:05:58 CEST)
ARTICLE
|
doi:10.20944/preprints202305.2044.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
relapsed germ cell tumors; salvage chemotherapy; conventional dose chemotherapy; high dose chemotherapy; autologous stem cell transplant
Online: 30 May 2023 (04:48:08 CEST)
ARTICLE
|
doi:10.20944/preprints202405.0845.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Small-cell lung cancer; Relapsed small-cell lung cancer; extensive-stage small-cell lung cancer; Paclitaxel; Gemcitabine; second-line treatment.
Online: 13 May 2024 (13:29:44 CEST)